Smith & Nephew PLC (SN) Income Statement

An income statement shows a company's revenue, expenses, and profit over a reporting period.

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally.

Total Revenue Chart for Smith & Nephew PLC

Smith & Nephew PLC (SN) revenue for FY2025 was GBP 6.3B, a 8.3% change from FY2024. Smith & Nephew PLC's revenue grew from GBP 609.4M in 1985 to GBP 6.3B in 2025 (932.7% over 40 years). Earnings per share grew from GBP 0.23 in 2000 to GBP 0.25 in 2022 (8.7%). Revenue compound annual growth rate: 5-year CAGR of 6.7%, 10-year CAGR of 3.1%, 20-year CAGR of 4.6%.

The most recent 8 years are real; the rest is blurred as a preview. Sign up free to unlock every line item, quarterly data, and the real full history. Free account: 8 years of history for 10 flagship companies. Premium: full history for 500+ companies. Premium is €10.00/month. See pricing.

Total Revenue (British Pounds)

R&D as % of Revenue

Compare with

Key Stats

Market Cap
£8.92B
Implied Share Price
£10.66
Enterprise Value
£11.16B
Revenue (TTM)
£6.30B
EBITDA
£1.38B
Profit Margin
10.08%
Trailing P/E
19.73
Forward P/E
13.09
Price/Book (MRQ)
2.35
Price/Sales (TTM)
1.42
EV/EBITDA
9.68
EV/Revenue
2.42
Dividend Yield
3.71%
Book Value
£4.50
Free Cash Flow (FY2025)
£869.88M
Free Cash Flow Yield
9.75%

Snapshot as of 27th August 2026 — not point-in-time controlled, may lag the live market by a few days.